Top Sell
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 0 | €2.26 | €7.00 | 209.735% |
| Trevena Inc. | 1 | 14 | 0 | 3 | €0.35 | €8.37 | 2263.390% |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 1 | €1.07 | €2.00 | 86.480% |
| Bayer AG ADR | 1 | 1 | 0 | 0 | €6.80 | €7.00 | 2.941% |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 0 | €2.82 | €30.00 | 963.830% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €35.60 | €50.00 | 40.449% |
| Tonix Pharmaceuticals Holding Corp. | 2 | 16 | 0 | 2 | €2.82 | €5.03 | 78.387% |
| Cytomx Therapeutics Inc | 2 | 2 | 2 | 2 | €4.12 | €50.00 | 1112.415% |
| Roche Holding AG ADR | 2 | 1 | 0 | 0 | €27.72 | €38.00 | 37.074% |
| Gritstone Oncology Inc | 2 | 2 | 0 | 0 | €0.89 | €6.53 | 632.586% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.62 | €3.00 | 380.154% |
| Cyclacel Pharmaceuticals Inc. | 2 | 12 | 1 | 0 | €0.22 | €14.66 | 6565.591% |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €6.90 | €7.00 | 1.449% |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €2.11 | €3.00 | 42.518% |
| Agenus Inc. | 2 | 2 | 0 | 0 | €0.41 | €7.30 | 1664.911% |
| Formycon AG | 3 | 1 | 0 | 0 | €43.55 | €100.00 | 129.621% |
| AEterna Zentaris Inc. | 3 | 20 | 0 | 2 | €1.87 | €14.02 | 649.759% |
| Merck KGaA | 3 | 1 | 0 | 0 | €152.15 | €146.00 | -4.042% |
| Palisade Bio Inc. | 3 | 1 | 2 | 0 | €0.34 | €21.06 | 6072.333% |
| Moleculin Biotech Inc | 3 | 27 | 1 | 2 | €0.41 | €18.42 | 4393.659% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.84 | €8.82 | 955.999% |
| Evotec SE | 4 | 1 | 0 | 0 | €9.79 | €21.50 | 119.724% |
| Novavax Inc. | 4 | 2 | 1 | 0 | €4.57 | €12.00 | 162.812% |
| Corvus Pharmaceuticals Inc | 4 | 1 | 0 | 1 | €1.56 | €5.10 | 226.229% |
| Sage Therapeutics Inc. | 5 | 3 | 1 | 1 | €12.96 | €26.71 | 106.133% |